Bio implants are biosynthetic materials used in medical applications to fix fractures, to replace a bone or to support the healing process of a damaged bone. Although the primary function of implant material is to provide stability to bone fractures, they also indirectly assist in the biological aspects of bone healing by minimizing micromotion at the bone-implant interface. Bio-implant has a wide range of application in cardiovascular, orthopedic, neurological, dental, and other therapeutic areas. Bio-implants are significant in improving longevity and quality of human life. Bio materials are those materials that are accepted by living tissues and can be used for tissue replacements. On a macroscopic level these devices are used to fix or replace a bone and to support its healing process. The commonly used surgical implants are usually made from one of the three types of materials: austenitic stainless steel, cobalt-chromium alloy, and titanium and its alloys and out of these, 316L austenitic stainless steel is the most commonly used implant material as it is cost effective

Market Dynamics

Rising cases of bone degeneration, increasing demand for minimally invasive surgeries, increasing launch of technologically advanced products, and approvals from regulatory bodies are expected to drive the global bio-implantmarket growth over the forecast period. For instance, on March 30, 2023, Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, announced that it has received market authorization for its RemeOs trauma screw in the U.S. The RemeOs trauma screw is the first and currently only bioresorbable metal implant that is approved by the U.S. Food and Drug Administration (FDA). The approved product range and indication align with the clinical trial conducted in the ankle.

Moreover, major operating players in the bio-implant market are focusing on expanding their presence in emerging economies that still adopt conventional methods of blood analysis.

Key features of the study:

• This report provides an in-depth analysis of the global bio-implant market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bio-implant market based on the following parameters –company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott, Dentsply Sirona Plc., Medtronic, Stryker Corporation, Zimmer Biomet, B.Braun, Cook Medical, C.R. Bard, Edwards Lifesciences, Wright Medical Technology, and Boston Scientific Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bio-implant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bio-implant market

Detailed Segmentation:

• Global Bio-implant Market, By Product Type:
  • Cardiovascular Implants
  • Dental Implants
  • Spinal Bio-implants
  • Orthopedic Implants
  • Ophthalmic Implants
  • Others
• Global Bio-implant Market, By Material Type:
  • Biomaterial Metal
  • Ceramic
  • Alloys
  • Polymer
• Global Bio-implant Market, By End User:
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
• Global Bio-implant Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Abbott. 
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dentsply Sirona Plc.
  • Medtronic
  • Stryker Corporation
  • Zimmer Biomet
  • B. Braun
  • Cook Medical
  • C. R. Bard
  • Edwards Lifesciences
  • Wright Medical Technology
  • Boston Scientific Corporation

 “*” marked represents similar segmentation in other categories in the respective section.